Tesamorelin, a manufactured substance closely resembling human growth hormone-releasing hormone ( GRF ), is mainly utilized in the treatment of HIV-associated lipodystrophy. This condition involves decrease of subcutaneous cells and increase of visceral deposits. While first approved for this specific purpose, ongoing research are looking into its